Literature DB >> 1109594

Purine nucleoside phosphorylase. Microheterogeneity and comparison of kinetic behavior of the enzyme from several tissues and species.

K C Agarwal, R P Agarwal, J D Stoeckler, R E Parks.   

Abstract

The purine nucleoside phosphorylases (PNPases) from human and rat erythrocytes and bovine spleen have been subjected to isoelectric focusing. The crystalline bovine spleen PNPase emerged as a single peak of pI = 5.4 whereas the rat erythrocytic PNPase was distributed into two variants of pI = 5.6 and 5.7 and the crystalline human erythrocytic enzyme produced six variants ranging from pI = 5.85 to 6.25. Treatment of human erythrocytic PNPase with dithiobisnitrobenzoate changed the enzyme to a more acidic form (pI = 5.05). The kinetic behaviors of these electrophoretic variants were studied and compared with the unresolved bovine erythrocytic PNPase. All six variants of the human erythrocytic PNPase and the two variants of rat erythrocytic PNPase displayed substrate activation at high concentrations of inosine and deoxyinosine. Bovine erythrocytic PNPase did not show activation with any of the nucleosides whereas with the bovine spleen enzyme activation occurred only with the deoxynucleosides, deoxyinosine and deoxyguanosine. The Km values for inosine, deoxyinosine, guanosine, deoxyguanosine, guanine, and hypoxanthine, where determined, ranged from 1.3 x 10-5 to 3.0 x 10-5 M for all the enzymes except the rat erythrocytic PNPase variants which have higher Km values for inosine (5.9 x 10-5 M, 8.3 x 10-5 M) and deoxyinosine (13 x 10-5 M, 20 x 10-5 M).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1109594     DOI: 10.1021/bi00672a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Purification and characterization of a novel nucleoside phosphorylase from a Klebsiella sp. and its use in the enzymatic production of adenine arabinoside.

Authors:  F Ling; Y Inoue; A Kimura
Journal:  Appl Environ Microbiol       Date:  1990-12       Impact factor: 4.792

2.  Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.

Authors:  S E Ealick; Y S Babu; C E Bugg; M D Erion; W C Guida; J A Montgomery; J A Secrist
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Metabolism of 2',3'-dideoxyinosine (ddI) in human blood.

Authors:  D J Back; S Ormesher; J F Tjia; R Macleod
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  Purification and characterization of purine nucleoside phosphorylase from Proteus vulgaris.

Authors:  M Surette; T Gill; S MacLean
Journal:  Appl Environ Microbiol       Date:  1990-05       Impact factor: 4.792

5.  Partial purification and properties of purine nucleoside phosphorylase from rabbit erythrocytes.

Authors:  B Savage; N Spencer
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

6.  A canine model of induced purine nucleoside phosphorylase deficiency.

Authors:  W R Osborne; H J Deeg; S J Slichter
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

7.  Rabbit erythrocyte purine nucleoside phosphorylase. Initial-velocity studies.

Authors:  B Savage; N Spencer
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

8.  Role of purine nucleoside phosphorylase in interactions between 2',3'-dideoxyinosine and allopurinol, ganciclovir, or tenofovir.

Authors:  Adrian S Ray; Loren Olson; Arnold Fridland
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

9.  Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases.

Authors:  Apirat Chaikuad; R Leo Brady
Journal:  BMC Struct Biol       Date:  2009-07-03

10.  Enhancing gold recovery from electronic waste via lixiviant metabolic engineering in Chromobacterium violaceum.

Authors:  Song Buck Tay; Gayathri Natarajan; Muhammad Nadjad bin Abdul Rahim; Hwee Tong Tan; Maxey Ching Ming Chung; Yen Peng Ting; Wen Shan Yew
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.